South Yorkshire Integrated Medicines Optimisation Committee

The South Yorkshire Integrated Medicines Optimisation Committee evaluates prescription products to determine the most appropriate care setting for their use in South Yorkshire and works collaboratively to develop treatment pathways across the South Yorkshire footprint.

SY IMOC form for supporting information to accompany proposals for prescribing guidelines and shared care protocols (new or updates to existing documents)

SY IMOC medicines traffic light drug list application form

SY Process for creating new and updating current Shared Care Protocols and prescribing guidelines

SY Amber G template

South Yorkshire IMOC Annual Report 2024

SY Integrated Medicines Optimisation Committee Meeting Minutes - 6 March 2024

SY Integrated Medicines Optimisation Committee Meeting Minutes - 5 February 2025

SY Integrated Medicines Optimisation Committee Terms of Reference

Shared Care Protocol For Epilepsy in Adults

Shared Care Protocol For the Treatment of Parkinson’s disease

Shared Care protocol for Sublingual Immunotherapy (SLIT) (Grazax®/Acarizax®)

Shared Care Protocol For The Use of Efmody® in Patients with Adrenal Insufficiency (CAH)

Shared Care Protocol For Denosumab 60mg/mL injection (Prolia®)

Shared Care Protocol Use of Liothyronine (T3) for the treatment of hypothyroidism in selected cohort of adults despite optimal dosage with levothyroxine and where alternative cause of symptoms have been excluded.

Shared Care Protocol For Alimemazine in the treatment of sleep disorders in Children

Shared Care Protocol of Finerenone in patients with Chronic Kidney Disease and Type 2 Diabetes

Guidance for patients on HRT with unscheduled bleeding

Shared Care Protocol for the use of Relugolix-estradiol-norethisterone acetate (Ryeqo®) for moderate to severe symptoms of uterine fibroids in adult patients

This list is in development and is being led by the South Yorkshire IMOC. Currently, it does not include medicines where Barnsley, Doncaster, Rotherham, Sheffield and Bassetlaw have previously agreed a placed-based Traffic Light status. Harmonisation of placed-based Traffic Light Drug List (TLDL) is underway with the long-term vision to have one TLDL for South Yorkshire.

NHS South Yorkshire Traffic Light Rationale and Criteria Document

NHS South Yorkshire Integrated Medicines Optimisation Committee (IMOC) Approved Traffic Light Drug List

Neurology: Migraine Management

Rimegepant (Vydura®) Supporting information for Acute Treatment of Migraine in Adults

Rimegepant For Treating a Migraine Attack Patient Information

Transfer of prescribing from private provider to NHS GP

South Yorkshire Self-Care Guidance

Guidance for Continuous Glucose Monitoring (CGM) in Adults and Children with Type 1 and Type 2 Diabetes

SYICB Position Statement on the prescribing of gabapentinoids

SY ICS Position statement Appropriate use of monitored Dosage Systems

South Yorkshire Valproate Guidance

Guidance for patients on HRT with unscheduled bleeding